Effect of Roflumilast on Pulmonary Function and Respiratory Symptoms in Patients With Chronic Obstructive Pulmonary Disease (COPD) (BY217/M2-110)

Completed · Phase 3

Conditions studied: Chronic Obstructive Pulmonary Disease, COPD

In brief

The aim of the study is to compare the effect of roflumilast and placebo on the lung function in patients with COPD.

Key facts

Study ID
NCT00062582
Run by
AstraZeneca
People needed
1000
Starts
2003-06-01
Last updated by the study team
2016-11-23

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.